Isabel, Sandra
Graña-Miraglia, Lucía
Gutierrez, Jahir M.
Bundalovic-Torma, Cedoljub
Groves, Helen E.
Isabel, Marc R.
Eshaghi, AliReza
Patel, Samir N.
Gubbay, Jonathan B.
Poutanen, Tomi
Guttman, David S.
Poutanen, Susan M.
Funding for this research was provided by:
Canadian Institutes of Health Research
Natural Sciences and Engineering Research Council of Canada (CP-151952)
Public Health Ontario, Canada
Article History
Received: 5 June 2020
Accepted: 30 July 2020
First Online: 20 August 2020
Competing interests
: Dr. Gubbay has received research Grants from GlaxoSmithKline Inc. and Hoffman-La Roche Ltd to study antiviral resistance in influenza, and from Pfizer Inc. to conduct microbiological surveillance of <i>Streptococcus pneumoniae</i>. These activities are not relevant to this study. Dr. Poutanen has received honoraria from Merck related to advisory boards and talks, honoraria from Verity, Cipher, and Paladin Labs related to advisory boards, partial conference travel reimbursement from Copan, and research support from Accelerate Diagnostics and bioMerieux, all outside the submitted work. All other authors declared that they have no competing interests.